QDEL

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 8

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273

Underlying: Common Stock · 273 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 7

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262

Underlying: Common Stock · 262 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 6

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875

Underlying: Common Stock · 875 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 5

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419

Underlying: Common Stock · 1,419 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 4

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,572

Underlying: Common Stock · 1,572 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 3

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,218

Underlying: Common Stock · 1,218 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · derivative · entry 2

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,954

Underlying: Common Stock · 1,954 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020500 · doc4.xml · nonDerivative · entry 1

POLAN MARY LAKE PH D · CIK 0001187716 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,653

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020501 · doc4.xml · derivative · entry 3

RHOADS ANN D · CIK 0001250252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128

Underlying: Common Stock · 128 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020501 · doc4.xml · derivative · entry 2

RHOADS ANN D · CIK 0001250252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427

Underlying: Common Stock · 427 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020501 · doc4.xml · nonDerivative · entry 1

RHOADS ANN D · CIK 0001250252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,248

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 26

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 357

Underlying: Common Stock · 357 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F20 · derivative.exercise_date: 357 shares will vest on January 31, 2023.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F20 · derivative.expiration_date: 357 shares will vest on January 31, 2023.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 25

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,190

Underlying: Common Stock · 1,190 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 24

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,545

Underlying: Common Stock · 13,545 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F19 · derivative.exercise_date: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.

F19 · derivative.expiration_date: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 23

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,878

Underlying: Common Stock · 12,878 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F18 · derivative.exercise_date: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.

F18 · derivative.expiration_date: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 22

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,559

Underlying: Common Stock · 1,559 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F17 · derivative.exercise_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

F17 · derivative.expiration_date: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 21

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,637

Underlying: Common Stock · 2,637 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F16 · derivative.exercise_date: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

F16 · derivative.expiration_date: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 20

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405

Underlying: Common Stock · 405 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 19

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,351

Underlying: Common Stock · 1,351 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 18

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 941

Underlying: Common Stock · 941 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F15 · derivative.exercise_date: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

F15 · derivative.expiration_date: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 17

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 16

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,052

Underlying: Common Stock · 1,052 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 15

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,320

Underlying: Common Stock · 3,320 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F14 · derivative.exercise_date: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F14 · derivative.expiration_date: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 14

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,033

Underlying: Common Stock · 1,033 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F13 · derivative.exercise_date: 1,033 shares will vest on November 18, 2022.

F13 · derivative.expiration_date: 1,033 shares will vest on November 18, 2022.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 13

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 824

Underlying: Common Stock · 824 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 12

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,749

Underlying: Common Stock · 2,749 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 11

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,623

Underlying: Common Stock · 3,623 shares

Expires not disclosed

F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F11 · derivative.exercise_date: 3,623 shares will vest on February 4, 2023.

F11 · derivative.expiration_date: 3,623 shares will vest on February 4, 2023.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 10

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,876

Underlying: Common Stock · 12,876 shares

Expires 2032-01-31

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 9

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,514

Underlying: Common Stock · 3,514 shares

Expires 2031-02-01

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F7 · derivative.exercise_date: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 8

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,935

Underlying: Common Stock · 2,935 shares

Expires 2030-09-14

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F6 · derivative.exercise_date: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 7

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,641

Underlying: Common Stock · 6,641 shares

Expires 2030-02-03

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F5 · derivative.exercise_date: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 6

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,246

Underlying: Common Stock · 7,246 shares

Expires 2029-02-04

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 5

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,212

Underlying: Common Stock · 9,212 shares

Expires 2028-01-16

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 4

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,343

Underlying: Common Stock · 14,343 shares

Expires 2027-02-15

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 3

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,596

Underlying: Common Stock · 17,596 shares

Expires 2026-02-10

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 2

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,798

Underlying: Common Stock · 8,798 shares

Expires 2025-02-05

F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020502 · doc4.xml · nonDerivative · entry 1

Bujarski Robert Joseph · CIK 0001333458 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,164

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020490 · doc4.xml · derivative · entry 8

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85

Underlying: Common Stock · 85 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020490 · doc4.xml · derivative · entry 7

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427

Underlying: Common Stock · 427 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020490 · doc4.xml · derivative · entry 6

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262

Underlying: Common Stock · 262 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020490 · doc4.xml · derivative · entry 5

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875

Underlying: Common Stock · 875 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F7 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020490 · doc4.xml · derivative · entry 4

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259

Underlying: Common Stock · 259 shares

Expires 2028-04-04

F4 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F5 · derivative.exercise_date: Vested in full.

SEC source: 0000899243-22-020490 · doc4.xml · nonDerivative · entry 3

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Birchview

Disclosed balance after: 38,145

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F3 · ownership.nature: The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Chief Executive Officer of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-020490 · doc4.xml · nonDerivative · entry 2

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · UGMA Account

Disclosed balance after: 16,630

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F2 · ownership.nature: The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0000899243-22-020490 · doc4.xml · nonDerivative · entry 1

Strobeck Matthew · CIK 0001377832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,533

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

SEC source: 0000899243-22-020481 · doc4.xml · derivative · entry 1

Busky Joseph M · CIK 0001385091 · Director · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,012

Underlying: Common Stock · 21,012 shares

Expires 2030-07-07

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.

F2 · derivative.exercise_date: 7,003 shares will vest on July 7, 2022 and 7,006 shares will vest on July 7, 2023.

SEC source: 0000899243-22-020482 · doc4.xml · derivative · entry 2

Dilsaver Evelyn S · CIK 0001391387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275

Underlying: Common Stock · 275 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, each Ortho restricted stock unit was converted into a restricted stock unit representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.

F4 · derivative.exercise_date: 204 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 71 shares will vest on March 31, 2023.

F4 · derivative.expiration_date: 204 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 71 shares will vest on March 31, 2023.

SEC source: 0000899243-22-020482 · doc4.xml · nonDerivative · entry 1

Dilsaver Evelyn S · CIK 0001391387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274

F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.

F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.

SEC source: 0000899243-22-020512 · doc4.xml · derivative · entry 7

Michael Edward L. · CIK 0001391823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166

Underlying: Common Stock · 166 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

SEC source: 0000899243-22-020512 · doc4.xml · derivative · entry 6

Michael Edward L. · CIK 0001391823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555

Underlying: Common Stock · 555 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.